Citius Pharmaceuticals Inc.
Organization details
- Legal name
- Citius Pharmaceuticals Inc.
- Former names
- Trail One, Inc. TrailOne, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Cranford
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- CTXR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001506251
- EIN
- 27-3425913
Board of directors
-
Carol Webb · DirectorSince 2023
-
Dennis M. Mcgrath · DirectorSince 2023
-
Eugene Myron Holuka · DirectorSince 2023
-
Leonard L. Mazur · Director · Chief Executive OfficerSince 2023
-
Myron Z. Holubiak · Director · Vice ChairmanSince 2023
-
Robert Joseph Smith · DirectorSince 2024
-
Suren G. Dutia · DirectorSince 2023
Chief executives
Director election results
Annual meeting of April 6, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
66.8%
-
69.0%
-
69.1%
-
69.1%
-
70.0%
-
70.7%
-
71.8%
Board connections
7 of this board's directors also sit on 3 other boards. 2 are in the same sector.
-
Citius Oncology Inc. Same sectorvia Carol Webb, Dennis M. Mcgrath, Eugene Myron Holuka, Leonard L. Mazur, Myron Z. Holubiak, Robert Joseph Smith and Suren G. Dutia
- via Leonard L. Mazur
-
DarioHealth Corp. Same sectorvia Dennis M. Mcgrath
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2024 | Eugene Myron Holuka Director | Option exercise | +2,415 | $0.02 | $48 |
| Mar 13, 2024 | Eugene Myron Holuka Director | Shares withheld for tax | −48 | $0.75 | $36 |
| Mar 4, 2024 | Carol Webb Director | Option exercise | +12,071 | $0.02 | $241 |
| Mar 4, 2024 | Carol Webb Director | Shares withheld for tax | −236 | $0.77 | $182 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Citius Pharmaceuticals Inc.
Who is the CEO of Citius Pharmaceuticals Inc.?
Leonard L. Mazur is Citius Pharmaceuticals Inc.'s Chief Executive Officer.
How many directors are on Citius Pharmaceuticals Inc.'s board?
Citius Pharmaceuticals Inc.'s board has 7 directors: Carol Webb, Dennis M. Mcgrath, Eugene Myron Holuka, Leonard L. Mazur, Myron Z. Holubiak, Robert Joseph Smith and Suren G. Dutia.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="citius-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.